Stephanie Trunk Named to Bloomberg BNA’s Pharmaceutical Law & Industry Report Advisory Board

Starting January 1, 2016, Ms. Trunk will be a formal resource for editors and reporters at Bloomberg BNA who are looking for analysis on the potential implications of important legal developments for the pharmaceutical industry.

A go-to resource for industry executives, the Pharmaceutical Law & Industry Report helps readers stay informed of regulatory and litigation developments affecting the pharmaceutical and biotech industries.

Ms. Trunk counsels pharmaceutical and device manufacturers, distributors and their customers, on regulatory, reimbursement, and compliance matters. Her practice extends to counseling on drug pricing and government price reporting, HIPAA and privacy matters, Medicare Part D, developing corporate compliance programs, and representing clients in contract negotiations and transactions.

Prior to joining Arent Fox, Ms. Trunk was legal counsel to a pharmacy benefit management company where she gave legal guidance on a variety of critical matters.